Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testingFARSHID, Gelareh; BALLEINE, Rosemary L; CUMMINGS, Margaret et al.The American journal of surgical pathology. 2006, Vol 30, Num 11, pp 1357-1366, issn 0147-5185, 10 p.Article

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapyWONG, Mark; BALLEINE, Rosemary L; COLLINS, Michael et al.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 6, pp 529-538, issn 0009-9236, 10 p.Article

HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysisHOUSSAMI, Nehmat; MACASKILL, Petra; BALLEINE, Rosemary L et al.Breast cancer research and treatment. 2011, Vol 129, Num 3, pp 659-674, issn 0167-6806, 16 p.Article

Development of a data entry auditing protocol and quality assurance for a tissue bank databaseKHUSHI, Matloob; CARPENTER, Jane E; BALLEINE, Rosemary L et al.Cell and tissue banking. 2012, Vol 13, Num 1, pp 9-13, issn 1389-9333, 5 p.Article

Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcomaBALLEINE, Rosemary L; EARLS, Peter J; WEBSTER, Lucy R et al.International journal of gynecological pathology. 2004, Vol 23, Num 2, pp 138-144, issn 0277-1691, 7 p.Article

DNA Replication Licensing and Progenitor Numbers Are Increased by Progesterone in Normal Human BreastGRAHAM, J. Dinny; MOTE, Patricia A; SALAGAME, Usha et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 7, pp 3318-3326, issn 0013-7227, 9 p.Article

Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancerBYRNE, Jennifer A; BALLEINE, Rosemary L; SLAMON, Dennis J et al.International journal of cancer. 2005, Vol 117, Num 6, pp 1049-1054, issn 0020-7136, 6 p.Article

Hormone-Responsive Model of Primary Human Breast EpitheliumDINNY GRAHAM, J; MOTE, Patricia A; SALAGAME, Usha et al.Journal of mammary gland biology and neoplasia. 2009, Vol 14, Num 4, pp 367-379, issn 1083-3021, 13 p.Article

Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian CancerSCURR, Lyndee L; GUMINSKI, Alexander D; KENNEDY, Catherine et al.Clinical cancer research (Print). 2008, Vol 14, Num 21, pp 6924-6932, issn 1078-0432, 9 p.Article

Poor-Prognosis Estrogen Receptor-Positive Breast Cancer Identified by Histopathologic SubclassificationWEBSTER, Lucy R; LEE, Shu-Fen; GREEN, Andrew R et al.Clinical cancer research (Print). 2008, Vol 14, Num 20, pp 6625-6633, issn 1078-0432, 9 p.Article

Predictors of vinorelbine pharmacokinetics and pharmacodvnamics in patients with cancerWONG, Mark; BALLEINE, Rosemary L; HOSKINS, Janelle M et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2448-2455, issn 0732-183X, 8 p.Article

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancerWONG, Mark; EVANS, Scott; RIVORY, Laurent P et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 1, pp 33-42, issn 0009-9236, 10 p.Article